Takeda Pharmaceutical Co. (TAK) Upgraded to Strong Buy: Here's What You Should Know
Investors might want to bet on Takeda Pharmaceutical Co. (TAK), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Takeda Pharmaceutical Co. is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock Prices
The change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Takeda Pharmaceutical Co. imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate Revisions
Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Rocket Lab Successfully Launches Its 66th Electron Rocket
Rocket Lab USA Inc. RKLB recently completed its 66th successful Electron rocket launch. The latest launch mission encompassed the deployment of the QPS-SAR-11 satellite into the Earth's mission is part of the contract that Rocket Lab secured in February 2025, from Japan-based Earth imaging company iQPS, marking one of its largest Electron launch agreements to date. This deal involves eight dedicated Electron launches, with six missions scheduled for 2025, out of which four are already completed, and two in successful missions reflect RKLB's proven expertise in launch services and further strengthen its footprint in the space industry. In the modern era of space exploration, factors like rapid technological advancements, the growing demand for satellite deployment, increasing commercial space activities and rising investments in space infrastructure are fueling the growth of the space launch services must have prompted the Grand View Research firm to estimate that the global space launch services market will witness a compound annual growth rate of 15.6% during the 2024-2030 time robust market growth prospects are expected to benefit companies like Rocket Lab. With its advanced Electron rocket and expanding capabilities in small satellite launches, the company is well-positioned to leverage the booming demand for frequent and cost-effective launches. It is also making strides in reusable rocket technology, which significantly reduces costs and improves launch capture further market shares, Rocket Lab is currently developing the Neutron rocket, designed for larger payloads and constellation deployments. This new product should further bolster RKLB's position in the market and fetch solid revenues. Other companies that are expected to enjoy the perks of the expanding global space launch services market have been discussed Grumman Corporation NOC: It is one of the key players in the space industry, providing launch vehicles and propulsion systems through its space systems division. The company's innovations in rocket technology and satellite deployment make it a significant beneficiary of the growing demand for space launch has a long-term (three to five years) earnings growth rate of 3.3%. The Zacks Consensus Estimate for NOC's 2025 sales indicates year-over-year growth of 2.8%.The Boeing Company BA and Lockheed Martin Corporation's LMT joint venture, United Launch Alliance ('ULA'), has been the United States' premier launch services provider since its establishment in 2006. The JV has successfully launched more than 150 Atlas and Delta rockets since has a long-term earnings growth rate of 18.1%, while that for Lockheed is pegged at 10.5%. The Zacks Consensus Estimates for BA and LMT's 2025 sales indicates year-over-year growth of 25.6 and 4.7%, respectively. Shares of RKLB have gained 501.3% in the past year compared with the industry's 42.2% growth. Image Source: Zacks Investment Research RKLB currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA) : Free Stock Analysis Report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Northrop Grumman Corporation (NOC) : Free Stock Analysis Report Rocket Lab Corporation (RKLB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
5 hours ago
- Yahoo
Will QXO INC (QXO) Gain on Rising Earnings Estimates?
QXO, Inc. (QXO) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight. The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008. For QXO INC, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year. The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate: For the current quarter, the company is expected to earn $0.09 per share, which is a change of -97.2% from the year-ago reported number. Over the last 30 days, the Zacks Consensus Estimate for QXO INC has increased 280% because one estimate has moved higher compared to no negative revisions. For the full year, the earnings estimate of $0.35 per share represents a change of +450% from the year-ago number. There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for QXO INC versus no negative revisions. This has pushed the consensus estimate 391.67% higher. The promising estimate revisions have helped QXO INC earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500. QXO INC shares have added 23.5% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report QXO, Inc. (QXO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
5 hours ago
- Yahoo
5 Broker-Favored Stocks to Watch Amid Cooling Inflation
Inflation is showing signs of cooling, while consumer spending is increasing. U.S. consumer prices increased less than expected in May as cheaper gasoline partially offset higher rents. This was the fourth consecutive month when the core inflation rise was less than expected. Consumer confidence rebounded in May, indicating that people now have more faith in the economy's prospects. Trade negotiations with several countries are ongoing. In this brightening scenario, monitoring broker-favorite stocks like BrightSpring Health Services BTSG, Allegiant Travel ALGT, CVR Energy CVI, Alta Equipment Group ALTG and Cracker Barrel Old Country Store CBRL appears prudent. We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company's top line, making the strategy a well-rounded one. # (Up- Down Rating)/ Total (4 weeks) =Top #75 (This gives the list of top 75 companies that have witnessed net upgrades over the last 4 weeks). % change in Q (1) est. (4 weeks) = Top #10 (This gives the top 10 stocks that have witnessed earnings estimate revisions over the past 4 weeks for the upcoming quarter). Price-to-Sales = Bot%10 (The lower the ratio, the better. Companies meeting this criterion are in the bottom 10% of our universe of over 7,700 stocks with respect to this ratio). Price greater than 5 (as a stock trading below $5 will not likely create significant interest for most of the investors). Average Daily Volume greater than 100,000 shares over the last 20 trading days (Volume has to be significant to ensure that these are easily traded). Market value ($ mil) = Top #3000 (This gives us stocks that are the top 3000 in terms of market capitalization). Com/ADR/Canadian= Com (This eliminates the ADR and Canadian stocks). Here are five of the 10 stocks that made it through the screen: BrightSpring: The company provides complementary and integrated home- and community-based pharmacy and health solutions for complex populations in need of specialized and/or chronic care. Through BTSG's service lines, including pharmacy, home health care and primary care, rehabilitation, and behavioral health, the company provides comprehensive care and clinical solutions in all 50 states to over 400,000 customers, clients, and patients daily. BrightSpring's 2025 earnings growth rate is pegged at 96.4%. The Zacks Consensus Estimate for BTSG's 2025 sales indicates a rise of 9.1% from 2024's actuals. The stock carries a Zacks Rank #2 (Buy) currently. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here Allegiant Travel is gaining from a buoyant air travel demand scenario. Efforts to upgrade its fleet are praiseworthy as well. ALGT aims to end 2025 with a fleet size of 122. ALGT's earnings surpassed estimates in three of the last four quarters (missing the mark once). The average beat was 32.7%. Allegiant currently carries a Zacks Rank #3 (Hold). Established in 2006, CVR Energy is a holding company primarily involved in renewable energy, petroleum refining, marketing and nitrogen fertilizer manufacturing through its stake in CVR Partners. It is committed to developing renewable biofuels and actively participating in the energy transition to reduce carbon emissions. CVI beat the Zacks Consensus Estimate for earnings in three of the trailing four quarters, missing the mark in the other. The company currently carries a Zacks Rank of 3. Alta Equipment Group is a leading provider of premium material handling, construction and environmental processing equipment and related services. ALTG, currently carrying a Zacks Rank #3, offers its customers a one-stop shop for their equipment needs through its broad, industry-leading product portfolio. ALTG has an expected earnings growth rate of 27.6% for the current year. The Zacks Consensus Estimate for June quarter earnings has been revised 10% upward over the past 60 days. Alta currently carries a Zacks Rank of 3. Cracker Barrel is prioritizing menu innovation and pricing to drive growth. The company is introducing the latest offerings, including shareable starters and specialty beverages, while optimizing pricing to enhance value. These initiatives aim to attract customers and support profitability. CBRL has outpaced the Zacks Consensus Estimate for earnings in three of the last four quarters, missing the mark on the other occasion, the average beat being 68.5%. CBRL shares have gained 7.4% over the past six months. CBRL currently carries a Zacks Rank #3. You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cracker Barrel Old Country Store, Inc. (CBRL) : Free Stock Analysis Report CVR Energy Inc. (CVI) : Free Stock Analysis Report Allegiant Travel Company (ALGT) : Free Stock Analysis Report Alta Equipment Group Inc. (ALTG) : Free Stock Analysis Report BrightSpring Health Services, Inc. (BTSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
